Similar Stories to Strong Sales Of Drugs, Vaccines, Propel Merck In 3q on Bing News

KENILWORTH, N.J. (AP) — Drugmaker Merck boosted its third-quarter profit by 55% and blew past Wall Street expectations, due to slightly higher sales, restrained spending and a small, one-time gain. The Kenilworth, New Jersey, company said it's making progress on three efforts to combat the coronavirus pandemic: two different vaccines and an antiviral drug. The maker of cancer blockbuster Keytruda on Tuesday reported net income of $2.94 billion, or $1.16 per share, up from $1.9 billion, or 74 cents per share, a year earlier. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, came to $1.74 per share.Read more on NewsOK.com

Topics:  n.j ap     drugmaker merck   wall street   the kenilworth   new jersey   keytruda   earnings   newsok   kenilworth   the   sales   vaccines   billion   costs   share   
BING NEWS:
  • Gossamer sells rights to drug it hopes can rival a new Merck therapy
    One analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing investors its drug seralutinib can compete on the market.
    05/6/2024 - 5:42 am | View Link
  • Merck may have a competition for ever-scarce BCG
    There’s long been a global shortage of the BCG vaccine for bladder cancer. But since ImmunityBio won FDA approval for Anktiva, an immunotherapy meant to be used along with the BCG vaccine, production ...
    05/6/2024 - 2:26 am | View Link
  • Merck highlights progress on HIV, hypertension, cervical cancer drugs
    - This May 1, 2018, shows Merck corporate headquarters in Kenilworth, N.J. RAHWAY, N.J. – Merck got off to an excellent start in the first quarter of 2024. Compared to the first quarter of 2023, ...
    04/25/2024 - 6:15 am | View Link
  • Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
    Merck on Thursday reported first-quarter results that beat analysts’ expectations amid strong sales of vaccines and cancer drug Keytruda.
    04/24/2024 - 11:31 pm | View Link
  • Merck Raises 2024 Profit Forecast on Strong Cancer, HPV Drugs Sales
    (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil.
    04/24/2024 - 7:33 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News